Caverject

Caverject (Alprostadil) is a medication used for the treatment of erectile dysfunction. It is administered via intracavernous injection and is manufactured by Pfizer S.A. in the EU.

Caverject, containing the active ingredient Alprostadil, is primarily used for the treatment of erectile dysfunction. This medication works by relaxing the smooth muscles in the penis, allowing for increased blood flow and facilitating an erection. It is often considered when other treatments for erectile dysfunction have not been effective. The primary use of Caverject is to help men achieve and maintain an erection suitable for sexual activity.

Common effects of Caverject may include pain at the injection site, prolonged erection, and, in rare cases, a condition known as priapism, which is a prolonged and painful erection lasting more than four hours. Some users may also experience dizziness, headaches, or mild bleeding at the injection site. These effects can vary from person to person and are not experienced by everyone who uses the medication.

Caverject should be used with caution and only under the guidance of a healthcare professional. It is important to follow the prescribed dosage and administration instructions to minimize the risk of side effects. Individuals with certain medical conditions, such as sickle cell anemia or leukemia, should avoid using Caverject. Always inform your healthcare provider about any existing medical conditions or medications you are taking before starting treatment with Caverject.

Caverject may interact with other medications, including those used to treat high blood pressure, heart conditions, or other erectile dysfunction treatments. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be avoided while using Caverject, as it can increase the risk of side effects. Always consult a healthcare professional for personalized advice regarding drug interactions.